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Summary: Brain-derived neurotrophic factor (BDNF), a
member of the neurotrophin family of neurotrophic fac-
tors, has important functions in the peripheral and cen-
tral nervous system of vertebrates. We have generated
bacterial artiﬁcial chromosome (BAC) transgenic mice
harboring 207 kb of the rat BDNF (rBDNF) locus contain-
ing the gene, 13 kb of genomic sequences upstream of
BDNF exon I, and 144 kb downstream of protein encod-
ing exon IX, in which protein coding region was replaced
with the lacZ reporter gene. This BDNF-BAC drove
transgene expression in the brain, heart, and lung, reca-
pitulating endogenous BDNF expression to a larger
extent than shorter rat BDNF transgenes employed pre-
viously. Moreover, kainic acid induced the expression of
the transgenic BDNF mRNA in the cerebral cortex and
hippocampus through preferential activation of pro-
moters I and IV, thus recapitulating neuronal activity-de-
pendent transcription of the endogenous BDNF gene.
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Brain-derived neurotrophic factor (BDNF), a member of
the neurotrophin family of proteins, supports the sur-
vival and differentiation of certain neuronal populations
during development (Bibel and Barde, 2000; Binder and
Scharfman, 2004). In the adult, BDNF regulates long-
term potentiation of synapses, thus playing a key role in
long-term memory formation (Lu et al., 2008). BDNF
was originally isolated from the brain, but it is also
expressed in the peripheral nervous system and non-
neural tissues (Binder and Scharfman, 2004). Changes in
BDNF gene expression accompany and contribute to
the development of various disorders of the nervous sys-
tem (Bibel and Barde, 2000).
The BDNF gene contains multiple promoters that initi-
ate the transcription of a number of distinct mRNAs,
each of which contains an alternative 50 untranslated
exon spliced to a common 30 protein coding exon. In
addition, the protein coding exon employs two different
polyadenylation sites that give rise to mRNA species
with 30 untranslated regions (UTRs) of different lengths.
Alternative promoter usage, differential splicing, and the
use of two different polyadenylation sites within each of
the transcription units generate at least 22 different
BDNF mRNAs in rodents and 34 BDNF mRNAs in human
that encode the same mature BDNF protein (Aid et al.,
2007; Pruunsild et al., 2007). It has been shown that the
subcellular localization of BDNF mRNAs and its regula-
tion by neuronal activity depends on the 50 exon and 30
UTRs used in the transcript (An et al., 2008; Chiaruttini
et al., 2008). In addition, it has been shown that BDNF
mRNAs containing the short 30 UTRs are more enriched
in polysomal fraction isolated from total brain than
BDNF mRNAs with the long 30 UTRs suggesting that
they are more efﬁciently translated (Timmusk et al.,
1994). Numerous regulatory elements involved in the
regulation of BDNF expression in vitro and in vivo have
been identiﬁed and characterized in different BDNF pro-
moters. Transcription factors such as REST (Timmusk
et al., 1999; Zuccato et al., 2003), CREB (Shieh et al.,
1998; Tao et al., 1998), NFkB (Lipsky et al., 2001), MEF2
(Flavell et al., 2008), NPAS4 (Lin et al., 2008), bHLHB2
(Jiang et al., 2008), and MeCP2 (Chen et al., 2003; Marti-
nowich et al., 2003) have been shown to regulate BDNF
expression in a promoter-speciﬁc manner. However, the
genomic regions including all necessary cis-acting
elements responsible for the tissue-speciﬁc and activity-
dependent BDNF gene regulation in vivo remain poorly
characterized. A few studies have addressed these issues
using transgenic mouse models (Funakoshi et al., 1998;
Guillemot et al., 2007; Koppel et al., 2009; Timmusk
et al., 1995, 1999).
In the present study, we have generated a transgenic
mouse line using a bacterial artiﬁcial chromosome (BAC)
clone containing 207 kb of rat BDNF (rBDNF) locus,
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of rBDNF exon I to 144 kb downstream of rBDNF coding
exon. Neighboring genes of the rBDNF gene lie 151 kb
upstream (Ifna4)a n d1 9 0k bd o w n s t r e a m( Sqrdl)f r o mi t
and therefore no additional genes/promoters were
included in the BAC construct. To facilitate detection of
transgene expression, we replaced the protein coding
region of exon IX in the rBDNF-BAC with lacZ reporter
gene (Fig. 1a). This should lead to the expression of func-
tional b-galactosidase protein but not a BDNF-lacZ fusion
protein. Functional b-galactosidase protein encoded by
the lacZ reporter gene in rBDNF-lacZ-BAC was detected
by transient expression in COS-7 cells (data not shown).
In the rBDNF-lacZ-BAC transgenic line, the expression
of rBDNF-lacZ mRNA was detected by RT-PCR in several
brain regions and peripheral organs expressing endoge-
nous mouse BDNF (mBDNF) mRNA (Fig. 1b). Speciﬁ-
cally, the expression of rBDNF-lacZ mRNA was detected
in the brain regions of cortex, hippocampus, cerebel-
lum, olfactory bulb, thalamus/hypothalamus, pons/me-
dulla, midbrain, striatum, and also in the heart and lung.
rBDNF-lacZ mRNA expression levels were not detected
by RT-PCR in the thymus, liver, kidney, spleen, and skele-
tal muscle. Particularly high expression of the transgene
was observed in the testis.
In the adult brain of the rBDNF-lacZ-BAC transgenic
mice, in situ hybridization analysis revealed intense
labeling of both rBDNF-lacZ and endogenous mBDNF
mRNAs in the cerebral cortex (Figs. 2a–f and 3g,h),
olfactory nucleus (Fig. 2a,b), hippocampus (Figs. 2e,f
and 3a–f), amygdala (Fig. 2e–f), nucleus of the lateral ol-
factory tract (Fig. 2i,j), and hypothalamic nuclei (Fig.
2e,f and 2k–n) including mamillary nuclei (Fig. 2k,l). In
the granular cell layer of the olfactory bulb (Fig. 2a,b),
caudate putamen, and nucleus accumbens (Fig. 2c,d),
high levels of rBDNF-lacZ mRNA were detected,
whereas labeling of the endogenous mBDNF mRNA was
indistinguishable from background signal. In the claus-
trum (Fig. 2c,d) and hypothalamus (Fig. 2e,f), rBDNF-
lacZ mRNA expression levels were relatively lower than
mBDNF mRNA levels. In the hippocampus, intensive
rBDNF-lacZ labeling over scattered neurons in the CA1
and CA3 subﬁelds (Fig. 3a,c) mirrored the expression of
the endogenous mBDNF (Fig. 3b,d). However, in the
granule cells of dentate gyrus that showed high expres-
sion of mBDNF mRNA (Figs. 2f and 3f) no expression of
rBDNF-lacZ was detected (Figs. 2e and 3e). In the cor-
tex, rBDNF-lacZ expression was observed in cingulate
and somatosensory areas in layers II–III and V–VI (Figs.
2c,e and 3g), whereas endogenous mBDNF was
expressed throughout layers II–VI (Figs. 2d,f and 3h).
Expression of rBDNF-lacZ (Fig. 2g,o) and mBDNF (Fig.
2h,p) mRNA was detected also in cardiac blood vessels
but not in ventricular myocardium (Fig. 2g,h). In lung tis-
sue, the levels of both rBDNF-lacZ and mBDNF mRNA
were below detection limits of our in situ hybridization
analysis (data not shown).
We also analyzed the expression and enzymatic activ-
ity of b-galactosidase protein in rBDNF-lacZ-BAC mouse
tissues. Reporter activity was not detected in the brain
or testis of the analyzed rBDNF-lacZ-BAC mouse line
using X-gal staining assay. In addition, no expression of
b-galactosidase protein was detected in the hippocam-
pus, cortex, and testis of the transgenic animals using
Western blot analysis (data not shown). These results
suggest that b-galactosidase protein was either not trans-
lated from BAC-driven rBDNF-lacZ mRNAs or the levels
of expression of the reporter protein remained below
detection limits of the methods used in this study.
Kainic acid has been shown to induce BDNF mRNA
expression in the adult rodent hippocampus and cere-
bral cortex (Zafra et al., 1990) in a promoter-speciﬁc
FIG. 1. (a) Schematic diagram of the BAC construct used for generating rBDNF-lacZ-BAC transgenic mice (thick lines). White boxes repre-
sent untranslated sequences and the blue ﬁlled box represents lacZ reporter gene that replaces the BDNF coding sequence. rBDNF-CAT
constructs (I–III and IV–VI) used by Timmusk et al. (1995) to generate rBDNF transgenic mice are shown with asterisks. (b) RT-PCR analysis
of rBDNF-lacZ mRNA expression driven by rBDNF promoters in transgenic mouse tissues. Abbreviations: mBDNF, mouse BDNF; HPRT,
hypoxanthine phosphoribosyltransferase 1; Cx, cortex; Hc, hippocampus; Cb, cerebellum; OB, olfactory bulb; TH, thalamus and hypothala-
mus; PM, pons/medulla; Mb, midbrain; St, striatum; Ty, thymus; He, heart; Lu, lung; Li, liver; Ki, kidney; SM, skeletal muscle; Sp, spleen; Te,
testis. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
215 RAT BDNF-BAC TRANSGENIC MICEmanner (Aid et al., 2007; Timmusk et al., 1993). Three
hours after systemic injection of kainic acid, the levels of
transgenic rBDNF-lacZ mRNA were increased in rBDNF-
lacZ-BAC mice similarly to endogenous mBDNF mRNA
(see Fig. 4). The elevated levels of rBDNF-lacZ and
mBDNF mRNA expression were observed in cortical
layers II–III and V–VI, hippocampal subﬁelds CA1 and
CA3, and in the amygdala. However, in contrast to en-
dogenous mBDNF, induction of rBDNF-lacZ mRNA
expression in the granule cells of the dentate gyrus was
not observed (Fig. 4e,f). Quantitative real-time PCR anal-
ysis showed that induction pattern of different rBDNF-
lacZ transcripts by kainic acid largely followed that of
the endogenous BDNF: both transgenic and endogenous
exon I and exon IV mRNAs transcribed from promoters I
and IV, respectively, showed higher levels of induction
than exon VI mRNAs transcribed from promoter VI
(Fig. 4g,h). Similarly to untreated mice, b-galactosidase
activity and protein expression was not detected in the
cortex, hippocampus, and testis of kainate-treated
rBDNF-lacZ-BAC mice (data not shown).
Transgenic mice expressing reporter genes under the
control of various regulatory regions of the rBDNF gene
have been described previously. rBDNF-CAT transgenic
mice carrying 9 kb of genomic sequence comprising
one or more BDNF 50 untranslated exons were reported
in (Timmusk et al., 1995). These transgenic mice
(Fig. 1a) recapitulated BDNF expression in most brain
regions and in the thymus. However, BDNF IV–VI con-
struct failed to recapitulate BDNF expression in the cere-
bellum, heart, and other peripheral tissues (Timmusk
et al., 1995) where BDNF transcripts IVand VI are endo-
genously expressed (Aid et al., 2007; Pruunsild et al.,
2007; Timmusk et al., 1993). Here we demonstrate that
rBDNF-lacZ-BAC including 50 kb of the rBDNF gene, 13
kb of upstream and 144 kb of downstream sequences
FIG. 2. In situ hybridization analysis of rBDNF-lacZ mRNA expression in adult rBDNF-lacZ-BAC transgenic mouse brain and heart. Photo-
micrographs of 16 lm coronal brain (a–f; i–n) and transverse heart sections (g,h,o,p) hybridized with
35S-labeled lacZ or mouse endogenous
BDNF (mBDNF) cRNA. The brain sections shown are at the levels of olfactory bulb (a,b), striatum (c,d), and hippocampus (e,f). (i–n) Magniﬁ-
cations of selected brain regions: LOT, nucleus of the lateral olfactory tract; MM, medial mammillary nucleus; DMH, dorsomedial hypothala-
mic nucleus; VMH, ventromedial hypothalamic nucleus. (o,p) Magniﬁcations of cardiac blood vessels. Scale bars: 1 mm (a–h) and 0.5 mm
(i–p). Abbreviations: Ctx, cortex; GrO, olfactory bulb, granular cell layer; ON, olfactory nuclei; CPu, caudate putamen; Cl, claustrum; NAc,
nucleus accumbens; Pir, piriform cortex; Hc, hippocampus; Th, thalamus; Hth, hypothalamus; Amy, amygdala; Ve, ventricle; V, cardiac
blood vessel.
216 KOPPEL ET AL.contains regulatory elements necessary for recapitula-
tion of endogenous BDNF expression in the brain, heart,
and lung, indicating that regulatory elements governing
BDNF mRNA expression in these tissues are located
within the 207 kb rat genomic sequence of the trans-
gene. In addition, neuronal activity induced expression
of rBDNF-lacZ mRNA in a promotor-speciﬁc manner in
the rBDNF-lacZ-BAC mice, mimicking induction of the
respective 50 exon-speciﬁc transcripts of endogenous
BDNF.
Recently, we have shown that human BDNF-EGFP-
BAC covering 67 kb of the human BDNF (hBDNF) gene,
84 kb of upstream and 17 kb of downstream sequences
are not sufﬁcient to drive EGFP (enhanced green ﬂuores-
cent protein) reporter gene expression in the heart
(Koppel et al., 2009). Expression of rBDNF-lacZ mRNA
in the heart of rBDNF-lacZ-BAC transgenic mice
reported here (with 144 kb region 30 of the rBDNF
FIG. 3. Cellular expression of rBDNF-lacZ mRNA in adult trans-
genic mouse brain: in situ hybridization analysis. (a–f) Bright-ﬁeld
photomicrographs of hippocampal subﬁelds CA1, CA3, and dentate
gyrus (DG). Hybridization probes are indicated above the columns;
closed arrowheads indicate neurons with strong labeling; open
arrowheads indicate neurons with weak or absent labeling; double
arrowheads indicate a glial cell showing no labeling. (g,h) Distribu-
tion of lacZ and mouse BDNF labeling in cortical layers I–VI. Abbre-
viation: CC, corpus callosum. Scale bars: 20 lm( a–f) and 100 lm
(g,h).
FIG. 4. Induction of rBDNF-lacZ mRNA in transgenic mouse brain
by kainic acid treatment. (a–f) In situ hybridization analysis with
probes for transgenic rBDNF-lacZ and mouse endogenous
(mBDNF) mRNA. Autoradiographs of sections from vehicle-treated
(a,b) and kainate-treated animals (c–f) are shown. Dark-ﬁeld autora-
diographs of coronal sections (a–d); high magniﬁcation bright-ﬁeld
photomicrographs of the dentate gyrus (e,f). Scale bar: 20 lm( e,f).
(g,h) Quantitative real-time PCR analysis of rBDNF-lacZ and endog-
enous mBDNF mRNA expression in the hippocampus (g) and cere-
bral cortex (h) of transgenic mice, expressed as fold difference rela-
tive to mRNA levels in vehicle-treated mice. Shown are transcripts
containing exons I, IV, VI, and total BDNF mRNA (BDNF S). Error
bars represent standard deviation of three RT-PCR experiments.
Abbreviations: CTR, vehicle-treated control mice; KA, kainate-
treated mice; CA1, CA3, hippocampal subﬁelds; DG, dentate gyrus;
Ctx, cortex; Amy, amygdala.
217 RAT BDNF-BAC TRANSGENIC MICEgene) suggests that a heart-speciﬁc regulatory element is
located within 18–144 kb 30 of BDNF gene. However,
this prediction should be treated with caution as regula-
tory regions of BDNF genes of different species are com-
pared. On the other hand, neither hBDNF-EGFP-BAC
(Koppel et al., 2009) nor rBDNF-lacZ-BAC could direct
transgene expression to hippocampal dentate granule
cells suggesting that the respective regulatory regions
are located in genomic regions further than 84 kb
upstream of BDNF exon I and 144 kb downstream of
BDNF coding exon. Existence of remote cis-acting ele-
ments controlling BDNF transcription has been demon-
strated by recent studies describing a regulatory region
850 kb upstream of human and mouse BDNF genes, dis-
ruption of which causes obesity, cognitive impairment,
and hyperactivity (Gray et al., 2006; Sha et al., 2007).
In conclusion, we have generated transgenic mice
containing rBDNF-lacZ-BAC transgene that recapitulated
the expression of endogenous BDNF mRNA in the brain
and peripheral tissues and neuronal activity-dependent
regulation of BDNF mRNA in the adult cerebral cortex
and hippocampus. This mouse model represents a useful
tool for further mapping of proximal and distal regula-
tory elements in rodent BDNF gene in vivo.
METHODS
rBDNF-lacZ-BAC transgenic mice were generated using
BAC clone CH230-106M15 (Chori BACPAC Resources,
Oakland, CA) modiﬁed to replace rBDNF coding
sequence with the lacZ reporter gene (Red
1/ET
1 ho-
mologous recombination technology, Gene Bridges, Hei-
delberg, Germany) (Muyrers et al., 1999). The BAC
clone contains 207 kb of the rBDNF genomic locus
(GenBank: AC108236) including 50 kb of rBDNF gene,
13 kb of 50 and 144 kb of 30 ﬂanking sequences (Fig. 1a).
Puriﬁed rBDNF-lacZ-BAC was transfected into COS-7
cells by DEAE-dextran and tested for reporter activity
using b-galactosidase assay. Transgenic mice were gener-
ated at the Karolinska Center for Transgene Technolo-
gies (Stockholm, Sweden) by injection of NotI-linearized
rBDNF-lacZ-BAC into CBA x C57Bl/6 mouse pronuclei.
One transgenic founder mouse was obtained and bred to
establish a transgenic mouse line. Integration of two
copies of rBDNF-lacZ-BAC transgene was estimated
by slot-blot hybridization of genomic DNA with
[a-
32P]dCTP-labeled lacZ-speciﬁc probe.
RNA isolation and analysis of rBDNF-lacZ mRNA
expression in transgenic mouse tissues with RT-PCR was
performed as described (Pruunsild et al., 2007). Quanti-
tative real-time PCR was performed on LightCycler 2.0
(Roche Diagnostics, Mannheim, Germany) using qPCR
Core Kit for SYBR
(r) Green I No ROX (Eurogentec, Lie `ge,
Belgium). qPCR reactions were processed in triplicate
and all expression data were normalized to hypoxan-
thine phosphoribosyltransferase 1 (HPRT1) mRNA lev-
els. For primer sequences see Table 1. In situ hybridiza-
tion analysis with [a-
35S]UTP-labeled cRNA probes for
rBDNF-lacZ and endogenous mouse BDNF mRNA was
performed as described in Timmusk et al. (1993). Kainic
Table 1
PCR Primers Used in This Study
BAC modiﬁcation
mrBDNF_rpsLneo_F TGTCTGTCTCTGCTTCCTTCCCACAGTTCCACCAGGTGAGAAGAGTGGGCCTGGTGATGATGGCGGGATCG
rBDNF_rpsLneo_R ATACAAATAGATAATTTTTGTCTCAATATAATCTATACAACATAAATCCATCAGAAGAACTCGTCAAGAAGG
BDNF_lacZ_300_F GCCGTCACTTGCTTAGAAACCGTT
BDNF_lacZ_300_R GAGTACTAACAAGAACGAAGATACT
Genotyping/RT-PCR
rBDNF_LacZ_F CCCTGCAGCTGGAGTGGATCAGTAAG
rBDNF_LacZ_R GAAGATCGCACTCCAGCCAGCTTTCC
mBDNF_F GTATGTTCGGGCCCTTACTATGGATAGC
mBDNF_R AAGTTGTGCGCAAATGACTGTTTC
HPRT1_F CTTTGCTGACCTGCTGGATTAC
HPRT1_R GTCCTTTTCACCAGCAAGCTTG
Quantitative real-time RT-PCR
Mouse endogenous mRNAs
mBDNFq_I_F TTGAAGCTTTGCGGATATTGCG
mBDNFq_IV_F GAAATATATAGTAAGAGTCTAGAACCTTG
mBDNFq_VI_F GCTTTGTGTGGACCCTGAGTTC
mBDNFq_RT_IXcod_R AAGTTGCCTTGTCCGTGGAC
mBDNFq_cod_F GGCCCAACGAAGAAAACCAT
mBDNFq_cod_R AGCATCACCCGGGAAGTGT
HPRT1q_F CAGTCCCAGCGTCGTGATTA
HPRT1q_R AGCAAGTCTTTCAGTCCTGTC
Rat BDNF-lacZ mRNAs
rBDNFq_I_F AGTCTCCAGGACAGCAAAGC
rBDNFq_IV_F GAAATATATAGTAAGAGTCTAGAACCTTG
rBDNFq_VI_F GCTTTGTGTGGACCCTGAGTTC
LacZq_F CGAAGTGACCAGCGAATACCTGT
LacZq_R1 CAACTGTTTACCTTGTGGAGCGACA
LacZq_R2 (with I_F) CAAGGCGATTAAGTTGGGTAAC
LacZq_R3 (with IV,VI_F) GTTTTCCCAGTCACGACGTT
218 KOPPEL ET AL.acid (KA; 30 mg/kg) or phosphate-buffered saline was
administered intraperitoneally to adult rBDNF-lacZ-BAC
mice weighing 20–25 g. Two kainic acid-treated and two
vehicle-treated animals were used for qRT-PCR analysis.
Four kainic acid-treated animals and one vehicle-treated
animal were used for in situ hybridization analysis. Only
animals with induced tonic-clonic seizures were selected
for analysis and results are shown for individuals show-
ing highest induction of transgenic and endogenous
BDNF mRNA. All animal procedures were carried out in
compliance with the local ethics committee.
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